Does detectable hs-cTnT predict death and cardiovascular outcomes in patients with chest pain and stable troponin levels?
In patients presenting with chest pain and stable troponin levels, even minimally detectable hs-cTnT is a prognostic marker for increased mortality and cardiovascular risk.
Among patients with chest pain and stable troponin levels, any detectable level of hs-cTnT is associated with an increased risk of death and cardiovascular outcomes and should merit further attention.
Roos et al. (2017) studied this question.